q1medicare.com
Powered by Q1Group LLC
A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu ☰
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search ⌕
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search ⌕

July 2017 summary of the new medications added to Medicare Part D prescription drug plan formularies (drug lists)

Category: Monthly Formulary Changes
Published: Jul, 17 2017 06:07:29
< Previous
Next >
The July, 2017 Medicare Part D plan formulary data (or drug list updates) includes the addition of 114 new National Drug Codes (NDCs) to the Medicare Part D program.  These NDCs represent 70 different drugs, many with multiple strengths.

Two new generic equivalents were added, Lopinavir-Ritonavir, the generic for Kaletra (r), and a new strength of Glyburide/Metformin, the generic for Glucovance (r).

What exactly is an NDC?
As a reminder, the NDC uniquely identifies a particular drug, manufacturer, strength, and packaging combination. The NDC for your medication is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the product and strength, and the third set of numbers identifies the packaging.

Why is there a new NDC?
New NDCs can be added to the Medicare Part D program for a number of reasons and a summary for all 43 new medications is as follows:

Reason for NDC Addition Occurrences
New Delivery Form and Strength 1
New Drug 16
New Drug and Strength 38
New Manufacturer 11
New Manufacturer and Delivery Form 1
New Manufacturer and Strength 24
New Manufacturer, Strength and Delivery Form
 2
New Packaging 4
New Strength 17
Total New NDCs 114

More about the newly added NDCs ...
The following chart details the first 114 new manufacturer / drug / strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates. You can click on the Drug Code (NDC) below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) to see the details of how this drug is covered by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.

NDC Drug Name Notes
64764015104ACTOS 15 MG TABLETNew Packaging
64764030114ACTOS 30 MG TABLETNew Packaging
64764045124ACTOS 45 MG TABLETNew Packaging
52427049601ADALAT CC 90 MG TABLETNew Manufacturer and Strength
69639010101AKYNZEO 300-0.5 MG CAPSULENew Drug
65862032730ALENDRONATE SODIUM 10 MG TABLETNew Manufacturer and Strength
00115168008ALENDRONATE SODIUM 40 MG TABLETNew Manufacturer and Strength
00115167608ALENDRONATE SODIUM 5 MG TABLETNew Manufacturer and Strength
00409416405AMINOSYN II 10% IV SOLUTIONNew Strength
00023590118ASACOL HD DR 800 MG TABLETNew Drug
65162059606Aspirin-Diphenhydramine ER 25-200 MGNew Drug
60842002201AUVI-Q 0.15 MG AUTO-INJECTORNew Drug and Strength
60842002301AUVI-Q 0.3 MG AUTO-INJECTORNew Drug and Strength
00781194133Azithromycin 500 mg tabletNew Strength
70515010510BETAPACE AF 80 MG TABLETNew Strength
51862053801BUTALBITAL/ACETAMINOPHEN 50-300 tabNew Manufacturer and Strength
23155062102Calcium Acetate 667 mg tabletNew Manufacturer
00187079630CARDIZEM CD 180 MG CAPSULENew Strength
43538017069CLINDACIN PAC KITNew Drug
00527172791CODEINE SULFATE 15 mg tabletNew Drug and Strength
00527169801CODEINE SULFATE 30 mg tabletNew Drug and Strength
00527169901CODEINE SULFATE 60 mg tabletNew Drug and Strength
62756052926Desmopressin ac 4 mcg/ml vialNew Manufacturer and Strength
68180059306Desvenlafaxine Succinate ER 100 mg [Pristiq]New Drug and Strength
00591406030Desvenlafaxine Succinate ER 25 mg tb [Pristiq]New Drug and Strength
68180059206Desvenlafaxine Succinate ER 50 mg tb [Pristiq]New Drug and Strength
42998050203EMFLAZA 18 MG TABLETNew Drug and Strength
42998050521EMFLAZA 22.75 MG/ML ORAL SUSPNew Drug and Strength
42998050303EMFLAZA 30 MG TABLETNew Drug and Strength
42998050403EMFLAZA 36 MG TABLETNew Drug and Strength
42998050101EMFLAZA 6 MG TABLETNew Drug and Strength
00115169549EPINEPHRINE 0.15 MG AUTO-INJECTNew Manufacturer
00115169449EPINEPHRINE 0.3 MG AUTO-INJECTNew Manufacturer
49502010202EPINEPHRINE 0.3 MG AUTO-INJECTNew Strength
51862029510FABIOR 0.1% FOAMNew Drug
43068011202FANAPT 12 MG TABLETNew Strength
00713022360Fluocinolone 0.01% creamNew Drug and Strength
00713032460Fluocinolone 0.025% creamNew Drug and Strength
52565001760Flurandrenolide 0.05% ointment [Cordran]New Manufacturer and Delivery Form
64980016905Hydroxyzine pam 25 mg capNew Manufacturer and Strength
64980017005Hydroxyzine pam 50 mg capNew Manufacturer and Strength
00338051914INTRALIPID 20% IV FAT EMULNew Drug and Strength
00338052013INTRALIPID 30% IV FAT EMULNew Drug and Strength
00085435001INTRON A 10 MILLION UNITS VIALNew Strength
00054025513Irbesartan-hctz 300-12.5 mg tb [Avalide]New Manufacturer and Strength
00078086001KISQALI 200 MG DAILY DOSENew Drug and Strength
00078086742KISQALI 400 MG DAILY DOSENew Drug and Strength
00078087463KISQALI 600 MG DAILY DOSENew Drug and Strength
66758017001KLOR-CON M10 tabletNew Drug and Strength
66758019005KLOR-CON M20 tabletNew Drug and Strength
70688050201KYNAMRO 200 MG/ML SYRINGENew Drug
60505250301Leflunomide 20 mg tabletNew Strength
00093414864Levalbuterol conc 1.25 mg/0.5New Packaging
00143957401Levetiracetam 500 mg/5 ml vialNew Manufacturer
00456120330LINZESS 72 MCG CAPSULENew Strength
68180050201Meloxicam 15 mg tabletNew Drug and Strength
68180050101Meloxicam 7.5 mg tabletNew Drug and Strength
49281048901MENOMUNE-A/C/Y/W-135 VIALNew Drug
23155010205Metformin hcl 500 mg tabletNew Manufacturer
00406182001Methylphenidate er 20 mg capNew Manufacturer
51862026301Methylphenidate er 20 mg capNew Manufacturer
00406184001Methylphenidate er 40 mg capNew Manufacturer
51862026501Methylphenidate er 40 mg capNew Manufacturer
51862026730Methylphenidate la 60 mg capNew Manufacturer
63323026530Methylprednisolone 125 mg vialNew Manufacturer and Strength
00781313670Methylprednisolone 40 mg/ml vlNew Manufacturer
00781313775Methylprednisolone 80 mg/ml vlNew Strength
68180091113MIBELAS 24 Fe chewable tabletNew Drug
75987009011Migergot suppositoryNew Drug
57237001106Mirtazapine 15 mg odtNew Manufacturer and Strength
65862002306Mirtazapine 45 mg odtNew Strength
65862056790Montelukast sod 4 mg tab chew [Singulair]New Manufacturer and Strength
65862056890Montelukast sod 5 mg tab chew [Singulair]New Manufacturer and Strength
66689003204MORPHINE SULFATE 10 mg/5 ml solnNew Manufacturer, Strength and Delivery Form
00406800312MORPHINE SULFATE 100 mg/5 ml solnNew Delivery Form and Strength
66689003304MORPHINE SULFATE 20 mg/5 ml solnNew Manufacturer, Strength and Delivery Form
00115164301NITROFURANTOIN MACROCRYSTALLINE 50 mg capNew Manufacturer and Strength
52544007101NORCO 5-325 TABLETNew Strength
00703334301OCTREOTIDE 1,000 mcg/ml vialNew Drug and Strength
00703331101OCTREOTIDE ACETATE 100 mcg/ml ampNew Drug and Strength
00703333301OCTREOTIDE ACETATE 200 mcg/ml vlNew Drug and Strength
00703330101OCTREOTIDE ACETATE 50 mcg/ml ampNew Drug and Strength
00703332101OCTREOTIDE ACETATE 500 mcg/ml ampNew Drug and Strength
60505008402Paroxetine hcl 30 mg tabletNew Manufacturer and Strength
55292060201PEGANONE 250 MG TABLETNew Drug
00603154258Potassium cl 10% (20 meq/15 ml)New Manufacturer and Strength
00603154358Potassium cl 20% (40 meq/15 ml)New Manufacturer and Strength
00781572005POTASSIUM CL ER 20 MEQ TABLETNew Manufacturer and Strength
00781571010POTASSIUM CHLORIDE 750MG EXTENDED RELEASE TABLETSNew Manufacturer and Strength
60846088201PRANDIN 1 MG TABLETNew Manufacturer and Strength
42799081201Prednisolone 10 mg/5 ml solnNew Manufacturer and Strength
42799081301Prednisolone 20 mg/5 ml solnNew Manufacturer and Strength
24090068388PRIMLEV 10-300 MG TABLETNew Drug and Strength
24090068188PRIMLEV 5-300 MG TABLETNew Drug and Strength
24090068288PRIMLEV 7.5-300 MG TABLETNew Drug and Strength
00378018701Propranolol 60 mg tabletNew Strength
50222020310PROTOPIC 0.03% OINTMENTNew Drug and Strength
50222021110PROTOPIC 0.1% OINTMENTNew Drug and Strength
49702021326RETROVIR 200 MG/20 ML VIALNew Strength
54766009306RIDAURA 3 MG CAPSULENew Drug
15370013010RYVENT 6 MG TABLETNew Drug
49702023308SELZENTRY 25 MG TABLETNew Strength
49702023508SELZENTRY 75 MG TABLETNew Strength
43538090012SYNALAR 0.025% CREAM KITNew Drug
00378048601Theophylline er 400 mg tabletNew Manufacturer and Strength
00378048701Theophylline er 600 mg tabletNew Manufacturer and Strength
00023590412TRELSTAR 11.25 MG SYRINGENew Drug and Strength
00023590204TRELSTAR 3.75 MG SYRINGENew Drug and Strength
70199001330TRIGLIDE 160 MG TABLETNew Drug
00603624021Trihexyphenidyl 2 mg tabletNew Strength
00074316290TRILIPIX DR 135 MG CAPSULENew Drug and Strength
00074316190TRILIPIX DR 45 MG CAPSULENew Drug and Strength
70183012584XERMELO 250 MG TABLETNew Drug
00143964201Zoledronic acid 4 mg/5 ml vial [Zometa]New Drug

Looking for a way to review any Medicare Part D plan formulary?
You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser at FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your service area using our Q1Rx.com.
*Please remember that a Medicare prescription drug plan can change their plan's formulary at any time throughout the year (adding or dropping drugs) and you can telephone your Medicare plan's Member Services department to learn about the most recent formulary changes - the toll-free number for Member Services is found on your Member ID card.

Additional Formulary Drug Change Articles:

Medicare Part D Plan Formulary (Drug Lists) Updates:
September 2023, August 2023, June 2023, May 2023, April 2023, March 2023, February 2023, August 2022, June 2022, May 2022, April 2022, March 2022, February 2022, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, June 2018, May 2018, April 2018, August 2017, July 2017, May 2017, April 2017, August 2016, July 2016, June 2016, April 2016, March 2016, October 2015, August 2015, July 2015, May 2015, April 2015, August 2014, May 2014, August 2013, June 2013, May 2013, April 2013, August 2012, July 2012, June 2012

Formulary Changes to the Top Medicare Drugs:
September 2023, September 2022, September 2021, September 2020, April 2020, September 2019, April 2019, August 2018, April 2018, August 2017, April 2017, August 2016, April 2016, October 2015, April 2015, August 2014, August 2013, April 2013

New Generic Equivalents Added to Formularies:
June 2023, February 2023, August 2021, June 2021, May 2021, April 2021, September 2020, August 2020, June 2020, May 2020, April 2020, March 2020, September 2019, July 2019, June 2019, May 2019, April 2019, March 2019, August 2018, July 2018, April 2018, August 2017, July 2017, April 2017, March & April 2016, April & May 2015, August 2014, May 2014


News Home
< Previous   Next >




Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs


News Categories
Selecting Your Medicare Plan
Star Ratings & Plan Quality
Annual Medicare Plan Changes
Enrollment Topics
Late Enrollment Penalty
Your Formulary (Drug List)
Monthly Formulary Changes
Your Medicare Plan Coverage
Pharmacies & Providers
Changing Medicare Plans
Special Enrollment Periods SEP
The Donut Hole or Coverage Gap
Donut Hole Discounts
Straddle Claims and High Costs
Out of Pocket: TrOOP and MOOP
Medicaid, LIS, & Extra Help
IRMAA - for Higher Incomes
Medicare Advantage Plans MAPD
Medicare Supplements - Medigap
Medicare Plan Providers
Marketing Medicare Products
General Medicare Part D PDP
General Medicare
Diabetes and Diabetic Coverage
Your Health & Wellness
About Q1Medicare.com




© Q1Group LLC 2005 - 2024  



Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.
.